ADMA Biologics Inc

ADMA Biologics, Inc. is a biopharmaceutical company that specialises in developing, manufacturing, and marketing plasma-derived therapies. It primarily aims to provide essential treatment options for patients living with immune deficiencies. The company predominantly operates within the USA. Operating within the healthcare sector, the firm focuses on producing intravenous immunoglobulin (IVIG) products. Its work aims to improve the health and quality of life for individuals requiring plasma-derived treatments for immune system disorders. Track the latest movements in the ADMA share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.